Fusion protein X, which combines a RAS-binding domain, a cell membrane-permeable peptide, and a third domain, inhibits the function of activated RAS and degrades it.
New concept to deplete the cellular nucleic acid pool against transient nucleic acid demand during viral replication
Orally available micelle-type branched-chain amino acid prodrug
Polymeric nanoparticles with high specificity compared to an existing drug
Dichloroacetate nanoparticle accumulates in cancer tissue by EPR effect.
Mucin secretion promotion for enhancement of intestinal epithelial barrier function by EPA metabolites produced by intestinal bacteria.
A drug candidate for the treatment of various fibrosis, incorporating a ligand for RIG-I, a pattern recognition receptor, as the active ingredient.
Induces migration of newly generated neurons to the injured area by improving the microenvironment of injured brain tissue.
Botulinum non-toxic hemagglutinin(bHA) fragment controls E-cadherin cell-cell adhesion
Improvement of cilial dysfunction by FGFR inhibitor through ICK/MAK pathway activation.
About Bionauts.jp
